论文部分内容阅读
目的 :探讨慢性阻塞性肺疾病评估测试(CAT)评分对COPD患者的预后预测作用以及临床应用。方法 :回顾性分析我院2013年5月~2014年5月期间慢性阻塞性肺疾病急性加重期108例患者的临床资料,并对患者的肺功能测定结果以及CAT量表评分结果进行统计分析。结果 :所有患者的FEV1%pred的平均值为(37.1±13.2)%,FEV1/FVC(%)的均值为(49.4±11.4)%,CAT的均值为(24±6),GOLD不同程度分级组间FEV1%pred、FEV1/FVC(%)和CAT评分差异具有统计学意义,且CAT评分与FEV1%pred呈负相关,CAT评分与FEV1/FVC(%)呈负相关,且随着CAT得分增高,患者的病死率越高。结论 :慢性阻塞性肺疾病评估测试(CAT)评分对COPD患者的疾病严重程度以及预后有一定的相关性,可以作为一项预后的指标,可在临床上推广应用。
Objective: To investigate the prognostic value of chronic obstructive pulmonary disease evaluation test (CAT) score in patients with COPD and its clinical application. Methods: The clinical data of 108 patients with acute exacerbation of chronic obstructive pulmonary disease in our hospital from May 2013 to May 2014 were analyzed retrospectively. The results of lung function test and CAT score were statistically analyzed. Results: The average FEV1% pred in all patients was (37.1 ± 13.2)%, the mean of FEV1 / FVC (%) was (49.4 ± 11.4)%, the mean of CAT was (24 ± 6) There was a significant difference between FEV1% pred, FEV1 / FVC (%) and CAT score, CAT score was negatively correlated with FEV1% pred and CAT score was negatively correlated with FEV1 / FVC , The higher the patient’s case fatality rate. Conclusion: The score of chronic obstructive pulmonary disease evaluation test (CAT) has a certain correlation with disease severity and prognosis in patients with COPD. It can be used as an index of prognosis and can be widely used clinically.